Rapport Therapeutics, Inc. (NASDAQ:RAPP) Cap table
Cap table
Built by 6ix from Rapport Therapeutics, Inc.’s releases · as of Nov 4, 2026
- Common shares
- 59,279,630
- Fully diluted
- 59,279,630
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 59,279,630 | Nov 2, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 59,279,630 |
| Nov 2, 2026 | 60,708,201 |
| Nov 2, 2026 | 59,279,630 |